iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
85 hedge funds and large institutions have $73.4M invested in iShares Genomics Immunology and Healthcare ETF in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 29 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
48% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 29
Holders
85
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.53M | |
| 2 | +$2.98M | |
| 3 | +$1.49M | |
| 4 |
WAP
Wealthcare Advisory Partners
West Chester,
Pennsylvania
|
+$1.2M |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$719K |
Top Sellers
| 1 | -$4.16M | |
| 2 | -$3.5M | |
| 3 | -$3.17M | |
| 4 |
SHJ
Sharkey, Howes & Javer
Denver,
Colorado
|
-$2.72M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.3M |